AMD/Retina Edition: Top Headlines for Week of August 29, 2022

In this edition, macular retinal nerve fiber layer thickness linked with cognitive decline; FDA approves Lucentis biosimilar; advanced visual field loss risk higher after glaucoma diagnosis in Black patients; and more.

Association found between macular retinal nerve fiber layer thickness, cognitive decline

FDA approves Cimerli as interchangeable biosimilar to Lucentis

Black patients have higher risk for advanced visual field loss after glaucoma diagnosis

iStent infinite cleared by FDA

Alcon to acquire Aerie Pharmaceuticals

References:

Kang JH, et al. Transl Vis Sci Technol. 2022;doi:10.1167/tvst.11.7.21.

Kim HM, et al. JAMA Ophthalmol. 2022;doi:10.1001/jamaophthalmol.2022.1563.

Press Release

Press Release

Press Release